We shown that, in distinction to classical opioid receptors, ACKR3 won't trigger classical G protein signaling and is not modulated through the classical prescription or analgesic opioids, which include morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Rather, we set up that LIH383, an ACKR3-selective subnanomolar https://nicholasm602uyu4.wikissl.com/user